02/09/2014 00:16:47 Free Membership Login

   

AVANIR Pharmaceuticals

Visual Financials
Company Name: AVANIR Pharmaceuticals
Ticker Symbol: AVNR
WWW Address: http://www.avanir.com
CEO: Keith Katkin
No. of Employees: 267
Common Issue Type: CS
Business Description:Avanir Pharmaceuticals is a biopharmaceutical company engaged in acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders.

 
Industry Information: DRUGS - Drugs - Generic [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 6.21 Up 0.2 6.08 6.25 6.03 6.22 5.97 1559245
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,067.1 171.8 0.00 -0.53 0.00 0.0 0.0 6.24 - 2.62
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close6.21$
PE Ratio - LTM0.0
Market Capitalisation1,067.1mil
Latest Shares Outstanding171.8mil
Earnings pS (EPS)-0.53$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee282,269$
Effective Tax Rate0.0%
Float130.5mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue1.20%
Research & Devlopment (R&D) as % of Revenue0.70%
Gross Profit Margin94.5%
EBITDA Margin-93.6%
Pre-Tax Profit Margin0.0%
Assets Turnover93.0%
Return on Assets (ROA)-93.1%
Return on Equity (ROE)-272.9%
Return on Capital Invested (ROCI)-125.7%
Current Ratio2.1
Leverage Ratio (Assets/Equity)4.1
Interest Cover-17.4
Total Debt/Equity (Gearing Ratio)1.59
LT Debt/Total Capital54.0%
Working Capital pS0.22$
Cash pS0.00$
Book-Value pS0.39$
Tangible Book-Value pS0.11$
Cash Flow pS-0.46$
Free Cash Flow pS-0.48$
KEY FIGURES (LTM): Price info
Price/Book Ratio16.03
Price/Tangible Book Ratio0.00
Price/Cash Flow-13.5
Price/Free Cash Flow-13.0
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----0.8-12,182,282
4 Weeks6.245.055.2414.7111,996,10239,922,046
13 Weeks6.244.895.0419.2151,982,159126,858,178
26 Weeks6.243.024.1644.5362,525,110320,689,033
52 Weeks6.242.625.3811.7-102,607,668654,524,702
YTD6.243.02-87.8782,421,972404,469,335
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
6.095.935.564.714.440.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.611.01.96
Income0.0
Dividend0.0
Capital SpendingNA
R&D11.72NA20.78
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %97.373.6293.2
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.040.010.06
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio48.70
Current Ratio2.0
Quick Ratio (Acid Test)1.9
Liquidity Ratio (Cash)1.62
Receivables Turnover7.6
Average Collection Period47
Working Capital/Equity200.5
Working Capital pS0.28
Cash-Flow pS-0.45
Free Cash-Flow pS-0.46
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio8.13
Financial Leverage Ratio (Assets/Equity)1.5
Debt Ratio38.5
Total Debt/Equity (Gearing Ratio)1.58
LT Debt/Equity1.15
LT Debt/Capital Invested47.7
LT Debt/Total Liabilities72.9
Interest Cover-17.4
Interest/Capital Invested9.93
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio14.05
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-15.17
Enterprise Value (EV)/Free Cash Flow-16.52
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM16.03
Price/Cash Flow Ratio-13.5
Price/Free Cash Flow Ratio - LTM-13.0
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-13.5
5-Y Low P/E Ratio-2.8
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.16
Current Liabilities pS0.26
Tangible Book Value pS - LTM0.11
Book Value pS - LTM0.39
Capital Invested pS0.28
Cash pS - LTM0.00
Cash Flow pS - LTM-0.46
Free Cash Flow pS - LTM-0.48
Earnings pS (EPS)-0.53
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-87.40
Free Cash Flow Margin 5YEAR AVG-420.17
Net Profit Margin-1.0
Net Profit Margin - 5YEAR AVRG.-4.5
Equity Productivity4.08
Return on Equity (ROE)-2.7
Return on Equity (ROE) - 5YEAR AVRG.-1.4
Capital Invested Productivity1.58
Return on Capital Invested (ROCI)-1.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.-1.1
Assets Productivity0.90
Return on Assets (ROA)-0.9
Return on Assets (ROA) - 5YEAR AVRG.-0.8
Gross Profit Margin94.5
Gross Profit Margin - 5YEAR AVRG.1.0
EBITDA Margin - LTM-93.6
EBIT Margin - LTM-94.7
Pre-Tax Profit Margin-4.5
Pre-Tax Profit Margin - 5YEAR AVRG.-4.5
Effective Tax Rate-0.0
Effective Tax Rate - 5YEAR AVRG.-0.0
EFFICIENCY RATIOS
Cash Conversion Cycle261,810
Revenue per Employee282,269
Net Income per Employee
Average Collection Period261,810
Receivables Turnover7.6
Day's Inventory Turnover Ratio
Inventory Turnover7.3
Inventory/Sales0.9
Accounts Payble/Sales18.34
Assets/Revenue1.11
Net Working Capital Turnover2.03
Fixed Assets Turnover17.79
Total Assets Turnover0.9
Revenue per $ Cash1.36
Revenue per $ Plant47.31
Revenue per $ Common Equity0.00
Revenue per $ Capital Invested1.57
Selling, General & Adm/tive (SG&A) as % of Revenue123.5
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue65.6
R&D Expense as % of Revenue - 5YEAR AVRG.65.6

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq avnr140902 00:16